ArticleJACC. Case reports2026
Surgical Bailout and Retrieval of Maldeployed Transcatheter Tricuspid Valve: Technical Considerations.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The necessity for surgeons to embrace transcatheter tricuspid valve therapy.JTCVS structural and endovascular · 2026Article
- Surgery for Failing Transcatheter Tricuspid Heart Valves.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo discuss the surgical considerations after a maldeployed Evoque transcatheter tricuspid valve replacement system. KEY STEPS: 1) Secure the delivery system at the groin to prevent further device displacement. 2) Safely access the chest and establish cardiopulmonary bypass; arresting the heart is not required. 3) Release each ventricular anchor sequentially in a rotational pattern. 4) Inspect the native tricuspid valve and decide intraoperatively on repair versus replacement. POTENTIAL PITFALLS: Failure to secure the delivery system may risk further device embolization. Central bicaval cannulation may crowd surgical field and make device removal more challenging. Failure to individually free each anchor risks damage to valve leaflets or chordae. Ice-cold saline for nitinol frame risks ventricular arrhythmia in a beating-heart setting and is not necessary. TAKE-HOME MESSAGES: Transcatheter tricuspid valve replacement maldeployment may warrant emergent surgical conversion. Although not technically challenging, patient comorbidities, prior operations, and location of the device all need to be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.